BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10581187)

  • 41. N-terminal truncated cytochrome P450 2B4: catalytic activities and reduction with alternative electron sources.
    Shumyantseva VV; Bulko TV; Alexandrova SA; Sokolov NN; Schmid RD; Bachmann T; Archakov AI
    Biochem Biophys Res Commun; 1999 Oct; 263(3):678-80. PubMed ID: 10512738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of the secondary structural motifs of P450BM-3 and the regions located upstream of the calmodulin-binding domain in the nitric oxide synthases.
    Uvarov VYu ; Lyashenko AA; Zimin AG
    Biochem Mol Biol Int; 1996 Mar; 38(3):553-8. PubMed ID: 8829615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Charge-dependent sidedness of cytochrome P450 forms studied by quartz crystal microbalance and atomic force microscopy.
    Schenkman JB; Jansson I; Lvov Y; Rusling JF; Boussaad S; Tao NJ
    Arch Biochem Biophys; 2001 Jan; 385(1):78-87. PubMed ID: 11361029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reaction of carbon monoxide and molecular oxygen with P450terp (CYP108) and P450BM-3 (CYP102).
    Sevrioukova IF; Peterson JA
    Arch Biochem Biophys; 1995 Mar; 317(2):397-404. PubMed ID: 7893155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Self-inactivation of cytochrome P-450 2B4 during catalytic cycle in the monooxygenase reconstituted system].
    Zgoda VG; Karuzina II; Archakov AI
    Vopr Med Khim; 1997; 43(4):217-25. PubMed ID: 9312936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.
    Zhang H; Gruenke L; Arscott D; Shen A; Kasper C; Harris DL; Glavanovich M; Johnson R; Waskell L
    Biochemistry; 2003 Oct; 42(40):11594-603. PubMed ID: 14529269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
    Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
    Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specificity of self-assembly of cytochrome P450.
    Myasoedova KN
    Biochemistry (Mosc); 1998 Dec; 63(12):1395-9. PubMed ID: 9916156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heme and apoprotein modification of cytochrome P450 2B4 during its oxidative inactivation in monooxygenase reconstituted system.
    Karuzina II; Zgoda VG; Kuznetsova GP; Samenkova NF; Archakov AI
    Free Radic Biol Med; 1999 Mar; 26(5-6):620-32. PubMed ID: 10218650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of mutation of the amino-terminal signal anchor sequence of cytochrome P450 2B4 on the enzyme structure and electron transfer processes.
    Lehnerer M; Schulze J; Pernecky SJ; Lewis DF; Eulitz M; Hlavica P
    J Biochem; 1998 Aug; 124(2):396-403. PubMed ID: 9685732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flavin-containing heme enzymes.
    Mowat CG; Gazur B; Campbell LP; Chapman SK
    Arch Biochem Biophys; 2010 Jan; 493(1):37-52. PubMed ID: 19850002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reductase and oxygenase activities of semisynthetic flavocytochromes based on cytochrome P450 2B4.
    Shumyantseva VV; Uvarov VY; Byakova OE; Archakov AI
    Biochem Mol Biol Int; 1996 Apr; 38(4):829-38. PubMed ID: 8728113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dithionite-supported hydroxylation of palmitic acid by cytochrome P450BM-3.
    Fang X; Halpert JR
    Drug Metab Dispos; 1996 Nov; 24(11):1282-5. PubMed ID: 8937865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of transient oxygen complexes of cytochrome p450 BM3 and nitric oxide synthase under high pressure.
    Marchal S; Girvan HM; Gorren AC; Mayer B; Munro AW; Balny C; Lange R
    Biophys J; 2003 Nov; 85(5):3303-9. PubMed ID: 14581231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatty acid hydroxylase of the fungus Fusarium oxysporum is possibly a fused protein of cytochrome P-450 and its reductase.
    Nakayama N; Shoun H
    Biochem Biophys Res Commun; 1994 Jul; 202(1):586-90. PubMed ID: 8037765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.
    Lewis DF; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 1999 Apr; 29(4):361-93. PubMed ID: 10375007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidation and electronic state dependence of proton transfer in the enzymatic cycle of cytochrome P450eryF.
    Harris DL
    J Inorg Biochem; 2002 Sep; 91(4):568-85. PubMed ID: 12237223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of a cytochrome P450-redox partner electron-transfer complex.
    Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
    Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
    J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.